Position in TEVA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$112,106
-$4,057 QoQ
Shares Held
3,722
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Covestor Ltd holds $1,065,409 across 32 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
14,651 | $197,934 | |
| 2 | ALKS |
Alkermes plc.
|
3,805 | $134,544 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
3,722 | $112,106 | |
| 4 | PRGO |
PERRIGO Co plc
|
7,804 | $83,814 | |
| 5 | ZTS |
Zoetis Inc.
|
605 | $71,517 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
1,044 | $61,877 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
467 | $61,522 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
661 | $50,136 |
All Filings in TEVA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $112,106 | 3,722 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $116,163 | 3,722 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $75,184 | 3,722 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $62,380 | 3,722 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $28,757 | 1,871 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $19,218 | 872 | Shares | Sole | 2025-02-13 | |
| 2024-06-30 | $105,641 | 6,501 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $91,729 | 6,501 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $66,816 | 6,400 | Shares | Sole | 2024-02-09 | |
| 2021-12-31 | $22,452 | 2,803 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||